Tilray Reports Unregistered Equity Sales on Jan 31

TL;DR

**Tilray just sold more shares privately, watch for potential dilution.**

AI Summary

Tilray Brands, Inc. filed an 8-K on February 6, 2024, reporting unregistered sales of equity securities that occurred on January 31, 2024. This filing indicates that Tilray issued shares without a public offering, which can dilute existing shareholders' ownership. Investors should be aware that such unregistered sales might increase the total number of outstanding shares, potentially impacting the stock's value per share.

Why It Matters

Unregistered sales of equity securities can dilute existing shareholder value by increasing the total number of shares outstanding without a public offering, potentially impacting the stock price.

Risk Assessment

Risk Level: medium — The risk is medium because unregistered equity sales can dilute existing shareholders, but the specific impact depends on the number of shares sold and the terms of the sale, which are not detailed in this filing.

Analyst Insight

A smart investor would monitor subsequent filings for details on the number of shares sold and the price, as this information is crucial to assess the actual dilution impact on their investment in Tilray Brands, Inc.

Key Players & Entities

• Tilray Brands, Inc. (company) — the registrant filing the 8-K
• January 31, 2024 (date) — date of the earliest event reported regarding unregistered sales of equity securities
• February 6, 2024 (date) — date the 8-K filing was made
• 001-38594 (other) — Commission File Number for Tilray Brands, Inc.
• TLRY (other) — trading symbol for Tilray Brands, Inc. Common Stock

FAQ

From the Filing

0001437749-24-003245.txt : 20240206 0001437749-24-003245.hdr.sgml : 20240206 20240206165238 ACCESSION NUMBER: 0001437749-24-003245 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240131 ITEM INFORMATION: Unregistered Sales of Equity Securities FILED AS OF DATE: 20240206 DATE AS OF CHANGE: 20240206 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tilray Brands, Inc. CENTRAL INDEX KEY: 0001731348 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 824310622 FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38594 FILM NUMBER: 24600968 BUSINESS ADDRESS: STREET 1: 655 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 BUSINESS PHONE: 519.322.8800 MAIL ADDRESS: STREET 1: 655 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 FORMER COMPANY: FORMER CONFORMED NAME: Tilray, Inc. DATE OF NAME CHANGE: 20180213 8-K 1 tlry20240205_8k.htm FORM 8-K tlry20220918_8k.htm false 0001731348 0001731348 2024-01-31 2024-01-31 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 31, 2024     Tilray Brands, Inc. (Exact name of Registrant as Specified in Its Charter)     Delaware 001-38594 82-4310622 (State or Other Jurisdiction (Commission File (IRS Employer of Incorporation) Number) Identification No.) 265 Talbot Street West ,     Leamington , ON   N8H 5L4 (Address of Principal Executive Offices,   (Zip Code) Registrant’s Telephone Number, Including Area Code: ( 844 ) 845-7291 Not applicable (Former Name or Former Address, if Changed Since Last Report)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:     ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)     ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)     ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))     ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class Trading Name of each exchange on which registered   Symbol(s)   Common Stock , $0.0001 par TLRY   value per share   The Nasdaq Global Select Market         Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐           Item 3.02           Unregistered Sales of Equity Securities.   Between January 10, 2024 and January 31, 2024, Tilray Brands, Inc. (the “Company”) entered into certain private debt-for-equity exchange transactions (the “Exchange Transactions”) with unrelated parties.  Pursuant to these Exchange Transactions, the Company issued an aggregate of 6,873,001 shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”), in exchange for $12,540,000 aggre